| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 5.49e-08 | 6 | 29 | 3 | GO:0015277 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 1.85e-06 | 17 | 29 | 3 | GO:0004970 | |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 2.21e-06 | 18 | 29 | 3 | GO:0015280 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 5.46e-06 | 24 | 29 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | gated channel activity | 7.19e-06 | 334 | 29 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 7.87e-06 | 27 | 29 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 8.37e-06 | 343 | 29 | 6 | GO:0005261 | |
| GeneOntologyMolecularFunction | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity | 1.22e-05 | 4 | 29 | 2 | GO:0050510 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 1.80e-05 | 229 | 29 | 5 | GO:0003714 | |
| GeneOntologyMolecularFunction | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity | 3.04e-05 | 6 | 29 | 2 | GO:0047238 | |
| GeneOntologyMolecularFunction | calcium channel activity | 3.48e-05 | 129 | 29 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 4.26e-05 | 7 | 29 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 4.33e-05 | 459 | 29 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 4.65e-05 | 465 | 29 | 6 | GO:0046873 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 4.80e-05 | 140 | 29 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | sodium channel activity | 5.80e-05 | 52 | 29 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 6.44e-05 | 151 | 29 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 7.29e-05 | 9 | 29 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 7.29e-05 | 9 | 29 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 7.64e-05 | 57 | 29 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 8.91e-05 | 60 | 29 | 3 | GO:0099529 | |
| GeneOntologyMolecularFunction | channel activity | 9.11e-05 | 525 | 29 | 6 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 9.21e-05 | 526 | 29 | 6 | GO:0022803 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.13e-04 | 65 | 29 | 3 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.13e-04 | 65 | 29 | 3 | GO:0022824 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.32e-04 | 562 | 29 | 6 | GO:0003712 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.66e-04 | 193 | 29 | 4 | GO:0015276 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 1.73e-04 | 75 | 29 | 3 | GO:0098960 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.80e-04 | 197 | 29 | 4 | GO:0022834 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.83e-04 | 14 | 29 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.87e-04 | 77 | 29 | 3 | GO:0005230 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 2.40e-04 | 627 | 29 | 6 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 3.26e-04 | 664 | 29 | 6 | GO:0008324 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 4.05e-04 | 100 | 29 | 3 | GO:0030594 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 4.67e-04 | 105 | 29 | 3 | GO:0015171 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 6.59e-04 | 758 | 29 | 6 | GO:0015318 | |
| GeneOntologyMolecularFunction | potassium channel activity | 8.32e-04 | 128 | 29 | 3 | GO:0005267 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 8.35e-04 | 793 | 29 | 6 | GO:0015075 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 9.23e-04 | 31 | 29 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | SNARE binding | 9.92e-04 | 136 | 29 | 3 | GO:0000149 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 1.11e-03 | 1160 | 29 | 7 | GO:0030674 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.18e-03 | 35 | 29 | 2 | GO:0015020 | |
| GeneOntologyMolecularFunction | acetylgalactosaminyltransferase activity | 1.18e-03 | 35 | 29 | 2 | GO:0008376 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 1.77e-03 | 43 | 29 | 2 | GO:0005231 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 1.79e-03 | 167 | 29 | 3 | GO:0015079 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.91e-03 | 171 | 29 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 2.03e-03 | 46 | 29 | 2 | GO:0005245 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 2.72e-03 | 1356 | 29 | 7 | GO:0060090 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 3.29e-03 | 207 | 29 | 3 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 3.33e-03 | 208 | 29 | 3 | GO:0005342 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 3.47e-03 | 211 | 29 | 3 | GO:0016758 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 6.18e-03 | 1180 | 29 | 6 | GO:0022857 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 8.03e-03 | 93 | 29 | 2 | GO:0097110 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 8.22e-03 | 288 | 29 | 3 | GO:0016757 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 8.62e-03 | 293 | 29 | 3 | GO:0008514 | |
| GeneOntologyMolecularFunction | transporter activity | 9.41e-03 | 1289 | 29 | 6 | GO:0005215 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.04e-02 | 152 | 29 | 2 | GO:0022843 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 2.07e-02 | 153 | 29 | 2 | GO:0008194 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission, glutamatergic | 6.35e-07 | 13 | 28 | 3 | GO:0051967 | |
| GeneOntologyBiologicalProcess | negative regulation of canonical Wnt signaling pathway | 1.86e-06 | 154 | 28 | 5 | GO:0090090 | |
| GeneOntologyBiologicalProcess | negative regulation of Wnt signaling pathway | 5.91e-06 | 195 | 28 | 5 | GO:0030178 | |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 6.41e-06 | 27 | 28 | 3 | GO:0035235 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 1.08e-05 | 32 | 28 | 3 | GO:0048266 | |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 2.14e-05 | 40 | 28 | 3 | GO:1990806 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 2.43e-05 | 126 | 28 | 4 | GO:0033555 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 2.91e-05 | 132 | 28 | 4 | GO:0035249 | |
| GeneOntologyBiologicalProcess | regulation of canonical Wnt signaling pathway | 3.68e-05 | 285 | 28 | 5 | GO:0060828 | |
| GeneOntologyBiologicalProcess | response to pain | 4.47e-05 | 51 | 28 | 3 | GO:0048265 | |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 6.92e-05 | 59 | 28 | 3 | GO:0007215 | |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | 8.98e-05 | 344 | 28 | 5 | GO:0060070 | |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway | 1.23e-04 | 368 | 28 | 5 | GO:0030111 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission | 1.72e-04 | 80 | 28 | 3 | GO:0050805 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 2.22e-04 | 663 | 28 | 6 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 2.24e-04 | 664 | 28 | 6 | GO:0099177 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 2.59e-04 | 92 | 28 | 3 | GO:0051966 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid secretion | 3.33e-04 | 20 | 28 | 2 | GO:0014051 | |
| GeneOntologyBiologicalProcess | chondroitin sulfate biosynthetic process | 3.33e-04 | 20 | 28 | 2 | GO:0030206 | |
| GeneOntologyBiologicalProcess | regulation of short-term neuronal synaptic plasticity | 4.04e-04 | 22 | 28 | 2 | GO:0048172 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 4.62e-04 | 112 | 28 | 3 | GO:0019226 | |
| GeneOntologyBiologicalProcess | regulation of anoikis | 5.66e-04 | 26 | 28 | 2 | GO:2000209 | |
| GeneOntologyBiologicalProcess | chondroitin sulfate proteoglycan biosynthetic process | 5.66e-04 | 26 | 28 | 2 | GO:0050650 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | 5.87e-04 | 516 | 28 | 5 | GO:0016055 | |
| GeneOntologyBiologicalProcess | inhibitory postsynaptic potential | 6.11e-04 | 27 | 28 | 2 | GO:0060080 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid transport | 6.57e-04 | 28 | 28 | 2 | GO:0015812 | |
| GeneOntologyBiologicalProcess | chondroitin sulfate metabolic process | 7.05e-04 | 29 | 28 | 2 | GO:0030204 | |
| GeneOntologyBiologicalProcess | regulation of presynaptic membrane potential | 8.60e-04 | 32 | 28 | 2 | GO:0099505 | |
| GeneOntologyBiologicalProcess | chondroitin sulfate proteoglycan metabolic process | 1.03e-03 | 35 | 28 | 2 | GO:0050654 | |
| GeneOntologyBiologicalProcess | anoikis | 1.15e-03 | 37 | 28 | 2 | GO:0043276 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | 1.33e-03 | 931 | 28 | 6 | GO:0098916 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | 1.33e-03 | 931 | 28 | 6 | GO:0007268 | |
| GeneOntologyBiologicalProcess | regulation of long-term neuronal synaptic plasticity | 1.34e-03 | 40 | 28 | 2 | GO:0048169 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | 1.39e-03 | 939 | 28 | 6 | GO:0099537 | |
| GeneOntologyBiologicalProcess | sulfur compound metabolic process | 1.41e-03 | 365 | 28 | 4 | GO:0006790 | |
| GeneOntologyBiologicalProcess | synaptic signaling | 1.70e-03 | 976 | 28 | 6 | GO:0099536 | |
| GeneOntologyBiologicalProcess | sulfur compound biosynthetic process | 1.77e-03 | 178 | 28 | 3 | GO:0044272 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 1.82e-03 | 180 | 28 | 3 | GO:0060078 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 1.93e-03 | 48 | 28 | 2 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 1.93e-03 | 48 | 28 | 2 | GO:1902656 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 4.29e-08 | 6 | 28 | 3 | GO:0032983 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 6.10e-07 | 13 | 28 | 3 | GO:1990907 | |
| GeneOntologyCellularComponent | sodium channel complex | 7.68e-06 | 29 | 28 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | cation channel complex | 1.37e-05 | 235 | 28 | 5 | GO:0034703 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 2.94e-05 | 45 | 28 | 3 | GO:0008328 | |
| GeneOntologyCellularComponent | presynaptic membrane | 3.02e-05 | 277 | 28 | 5 | GO:0042734 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 4.04e-05 | 50 | 28 | 3 | GO:0098878 | |
| GeneOntologyCellularComponent | transcription regulator complex | 1.16e-04 | 596 | 28 | 6 | GO:0005667 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.31e-04 | 378 | 28 | 5 | GO:0034702 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.81e-04 | 405 | 28 | 5 | GO:0045211 | |
| GeneOntologyCellularComponent | perikaryon | 2.11e-04 | 223 | 28 | 4 | GO:0043204 | |
| GeneOntologyCellularComponent | terminal bouton | 2.83e-04 | 96 | 28 | 3 | GO:0043195 | |
| GeneOntologyCellularComponent | potassium channel complex | 3.58e-04 | 104 | 28 | 3 | GO:0034705 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 4.49e-04 | 272 | 28 | 4 | GO:0090575 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 5.87e-04 | 523 | 28 | 5 | GO:1902495 | |
| GeneOntologyCellularComponent | neuronal cell body | 7.07e-04 | 835 | 28 | 6 | GO:0043025 | |
| GeneOntologyCellularComponent | transporter complex | 7.37e-04 | 550 | 28 | 5 | GO:1990351 | |
| GeneOntologyCellularComponent | dendrite | 8.15e-04 | 858 | 28 | 6 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 8.25e-04 | 860 | 28 | 6 | GO:0097447 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 9.44e-04 | 1228 | 28 | 7 | GO:0036477 | |
| GeneOntologyCellularComponent | synaptic membrane | 9.58e-04 | 583 | 28 | 5 | GO:0097060 | |
| GeneOntologyCellularComponent | presynapse | 9.64e-04 | 886 | 28 | 6 | GO:0098793 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.19e-03 | 157 | 28 | 3 | GO:0098839 | |
| GeneOntologyCellularComponent | cell body | 1.23e-03 | 929 | 28 | 6 | GO:0044297 | |
| GeneOntologyCellularComponent | dendrite cytoplasm | 1.24e-03 | 39 | 28 | 2 | GO:0032839 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.73e-03 | 46 | 28 | 2 | GO:0005891 | |
| GeneOntologyCellularComponent | postsynapse | 1.97e-03 | 1018 | 28 | 6 | GO:0098794 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 2.40e-03 | 201 | 28 | 3 | GO:0099634 | |
| GeneOntologyCellularComponent | distal axon | 2.55e-03 | 435 | 28 | 4 | GO:0150034 | |
| GeneOntologyCellularComponent | axon terminus | 2.72e-03 | 210 | 28 | 3 | GO:0043679 | |
| GeneOntologyCellularComponent | membrane protein complex | 2.97e-03 | 1498 | 28 | 7 | GO:0098796 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 3.53e-03 | 785 | 28 | 5 | GO:0098797 | |
| GeneOntologyCellularComponent | neuron projection terminus | 3.65e-03 | 233 | 28 | 3 | GO:0044306 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 4.19e-03 | 817 | 28 | 5 | GO:0098978 | |
| GeneOntologyCellularComponent | calcium channel complex | 4.29e-03 | 73 | 28 | 2 | GO:0034704 | |
| GeneOntologyCellularComponent | Golgi cisterna membrane | 7.01e-03 | 94 | 28 | 2 | GO:0032580 | |
| GeneOntologyCellularComponent | receptor complex | 7.12e-03 | 581 | 28 | 4 | GO:0043235 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 8.68e-03 | 1377 | 28 | 6 | GO:0140513 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 9.49e-03 | 110 | 28 | 2 | GO:0120111 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 1.12e-02 | 350 | 28 | 3 | GO:0098802 | |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 1.21e-02 | 125 | 28 | 2 | GO:0140534 | |
| GeneOntologyCellularComponent | Golgi cisterna | 1.40e-02 | 135 | 28 | 2 | GO:0031985 | |
| Domain | Groucho/TLE_N | 6.27e-15 | 5 | 29 | 5 | IPR005617 | |
| Domain | TLE_N | 6.27e-15 | 5 | 29 | 5 | PF03920 | |
| Domain | Groucho_enhance | 2.34e-11 | 5 | 29 | 4 | IPR009146 | |
| Domain | Prefoldin | 8.17e-08 | 72 | 29 | 5 | IPR009053 | |
| Domain | PBPe | 2.70e-06 | 18 | 29 | 3 | SM00079 | |
| Domain | Iono_rcpt_met | 2.70e-06 | 18 | 29 | 3 | IPR001508 | |
| Domain | Glu/Gly-bd | 2.70e-06 | 18 | 29 | 3 | IPR019594 | |
| Domain | Iontro_rcpt | 2.70e-06 | 18 | 29 | 3 | IPR001320 | |
| Domain | Lig_chan | 2.70e-06 | 18 | 29 | 3 | PF00060 | |
| Domain | Lig_chan-Glu_bd | 2.70e-06 | 18 | 29 | 3 | SM00918 | |
| Domain | Lig_chan-Glu_bd | 2.70e-06 | 18 | 29 | 3 | PF10613 | |
| Domain | ANF_receptor | 2.52e-05 | 37 | 29 | 3 | PF01094 | |
| Domain | ANF_lig-bd_rcpt | 2.52e-05 | 37 | 29 | 3 | IPR001828 | |
| Domain | Peripla_BP_I | 2.96e-05 | 39 | 29 | 3 | IPR028082 | |
| Domain | Ca_chan_IQ | 4.87e-05 | 7 | 29 | 2 | PF08763 | |
| Domain | GPHH | 4.87e-05 | 7 | 29 | 2 | PF16905 | |
| Domain | GPHH_dom | 4.87e-05 | 7 | 29 | 2 | IPR031649 | |
| Domain | VDCC_a1su_IQ | 4.87e-05 | 7 | 29 | 2 | IPR014873 | |
| Domain | Ca_chan_IQ | 4.87e-05 | 7 | 29 | 2 | SM01062 | |
| Domain | Chond_GalNAc | 6.48e-05 | 8 | 29 | 2 | IPR008428 | |
| Domain | CHGN | 6.48e-05 | 8 | 29 | 2 | PF05679 | |
| Domain | VDCCAlpha1 | 1.04e-04 | 10 | 29 | 2 | IPR002077 | |
| Domain | WD40_repeat_CS | 1.15e-04 | 164 | 29 | 4 | IPR019775 | |
| Domain | WD40 | 6.53e-04 | 259 | 29 | 4 | PF00400 | |
| Domain | Ion_trans_dom | 7.21e-04 | 114 | 29 | 3 | IPR005821 | |
| Domain | Ion_trans | 7.21e-04 | 114 | 29 | 3 | PF00520 | |
| Domain | WD40 | 7.42e-04 | 268 | 29 | 4 | SM00320 | |
| Domain | WD40_repeat | 7.84e-04 | 272 | 29 | 4 | IPR001680 | |
| Domain | WD_REPEATS_1 | 8.51e-04 | 278 | 29 | 4 | PS00678 | |
| Domain | WD_REPEATS_2 | 8.62e-04 | 279 | 29 | 4 | PS50082 | |
| Domain | WD_REPEATS_REGION | 8.62e-04 | 279 | 29 | 4 | PS50294 | |
| Domain | WD40_repeat_dom | 1.09e-03 | 297 | 29 | 4 | IPR017986 | |
| Domain | - | 1.66e-03 | 333 | 29 | 4 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.69e-03 | 335 | 29 | 4 | IPR015943 | |
| Domain | Channel_four-helix_dom | 3.52e-03 | 57 | 29 | 2 | IPR027359 | |
| Domain | - | 3.52e-03 | 57 | 29 | 2 | 1.20.120.350 | |
| Domain | - | 6.99e-03 | 81 | 29 | 2 | 3.90.550.10 | |
| Domain | Nucleotide-diphossugar_trans | 8.20e-03 | 88 | 29 | 2 | IPR029044 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 3.45e-11 | 14 | 27 | 5 | M27402 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 2.22e-09 | 10 | 27 | 4 | MM15156 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.55e-07 | 26 | 27 | 4 | MM14793 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 3.70e-07 | 32 | 27 | 4 | MM14975 | |
| Pathway | REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX | 5.15e-07 | 85 | 27 | 5 | M27079 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 7.45e-07 | 10 | 27 | 3 | M10272 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 1.14e-06 | 42 | 27 | 4 | M27272 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 1.36e-06 | 12 | 27 | 3 | MM15142 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.96e-06 | 48 | 27 | 4 | M611 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 1.12e-05 | 74 | 27 | 4 | M616 | |
| Pathway | REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX | 1.45e-05 | 79 | 27 | 4 | MM14754 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 1.53e-05 | 80 | 27 | 4 | M223 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 2.46e-05 | 30 | 27 | 3 | M18193 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 2.55e-05 | 91 | 27 | 4 | M27101 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 2.99e-05 | 32 | 27 | 3 | MM15143 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 3.07e-05 | 330 | 27 | 6 | M7847 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 4.42e-05 | 211 | 27 | 5 | MM14502 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CHONDROITIN_SULFATE_BIOSYNTHESIS | 9.82e-05 | 8 | 27 | 2 | M47920 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.42e-04 | 270 | 27 | 5 | M15514 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.92e-04 | 11 | 27 | 2 | M47958 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.92e-04 | 11 | 27 | 2 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.92e-04 | 11 | 27 | 2 | M26913 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 2.09e-04 | 61 | 27 | 3 | MM15071 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 2.18e-04 | 158 | 27 | 4 | MM14791 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 3.42e-04 | 72 | 27 | 3 | MM14631 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 3.86e-04 | 335 | 27 | 5 | MM14503 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 4.33e-04 | 78 | 27 | 3 | M1921 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | 5.92e-04 | 19 | 27 | 2 | MM14800 | |
| Pathway | WNT_SIGNALING | 6.38e-04 | 89 | 27 | 3 | M5493 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | 6.57e-04 | 20 | 27 | 2 | M658 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE | 7.97e-04 | 22 | 27 | 2 | M19166 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 8.72e-04 | 23 | 27 | 2 | M47666 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 9.47e-04 | 233 | 27 | 4 | M27099 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 9.77e-04 | 411 | 27 | 5 | M735 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.03e-03 | 25 | 27 | 2 | M47948 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 1.04e-03 | 239 | 27 | 4 | MM14756 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.12e-03 | 108 | 27 | 3 | M17034 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.16e-03 | 246 | 27 | 4 | M10189 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 1.68e-03 | 272 | 27 | 4 | M13380 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 2.14e-03 | 36 | 27 | 2 | M1315 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 2.35e-03 | 140 | 27 | 3 | M42572 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 2.55e-03 | 144 | 27 | 3 | MM14501 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.70e-03 | 147 | 27 | 3 | MM15854 | |
| Pathway | WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS | 2.77e-03 | 41 | 27 | 2 | M48095 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.92e-03 | 151 | 27 | 3 | M39329 | |
| Pathway | PID_PS1_PATHWAY | 3.47e-03 | 46 | 27 | 2 | M70 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 3.62e-03 | 47 | 27 | 2 | M19708 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | 3.77e-03 | 48 | 27 | 2 | MM14696 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | 4.09e-03 | 50 | 27 | 2 | M678 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 4.42e-03 | 52 | 27 | 2 | M5785 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 4.63e-03 | 178 | 27 | 3 | M2890 | |
| Pubmed | 2.80e-16 | 5 | 29 | 5 | 8365415 | ||
| Pubmed | 1.68e-15 | 6 | 29 | 5 | 8573724 | ||
| Pubmed | A Gro/TLE-NuRD corepressor complex facilitates Tbx20-dependent transcriptional repression. | 5.88e-15 | 7 | 29 | 5 | 24024827 | |
| Pubmed | 1.57e-14 | 8 | 29 | 5 | 16002402 | ||
| Pubmed | All Tcf HMG box transcription factors interact with Groucho-related co-repressors. | 2.21e-13 | 12 | 29 | 5 | 11266540 | |
| Pubmed | 3.90e-13 | 4 | 29 | 4 | 11290324 | ||
| Pubmed | 3.90e-13 | 4 | 29 | 4 | 8645603 | ||
| Pubmed | 1.95e-12 | 5 | 29 | 4 | 1303260 | ||
| Pubmed | 1.95e-12 | 5 | 29 | 4 | 8989517 | ||
| Pubmed | 5.84e-12 | 6 | 29 | 4 | 8892234 | ||
| Pubmed | Expression of Groucho/TLE proteins during pancreas development. | 1.18e-11 | 24 | 29 | 5 | 18778483 | |
| Pubmed | A comparison of Notch, Hes and Grg expression during murine embryonic and post-natal development. | 2.72e-11 | 8 | 29 | 4 | 10512199 | |
| Pubmed | Nolz1 promotes striatal neurogenesis through the regulation of retinoic acid signaling. | 2.72e-11 | 8 | 29 | 4 | 20735826 | |
| Pubmed | 8.15e-11 | 10 | 29 | 4 | 30571765 | ||
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 1.28e-10 | 11 | 29 | 4 | 15499562 | |
| Pubmed | 2.77e-10 | 13 | 29 | 4 | 22735158 | ||
| Pubmed | 3.88e-10 | 14 | 29 | 4 | 17202186 | ||
| Pubmed | 5.21e-10 | 3 | 29 | 3 | 8808280 | ||
| Pubmed | 5.21e-10 | 3 | 29 | 3 | 31513786 | ||
| Pubmed | Differential trafficking of GluR7 kainate receptor subunit splice variants. | 5.21e-10 | 3 | 29 | 3 | 15805114 | |
| Pubmed | Tle corepressors are differentially partitioned to instruct CD8+ T cell lineage choice and identity. | 5.21e-10 | 3 | 29 | 3 | 30045946 | |
| Pubmed | Kainate receptor-mediated responses in the CA1 field of wild-type and GluR6-deficient mice. | 5.21e-10 | 3 | 29 | 3 | 9880586 | |
| Pubmed | 5.29e-10 | 15 | 29 | 4 | 9291577 | ||
| Pubmed | 1.18e-09 | 18 | 29 | 4 | 33658226 | ||
| Pubmed | 1.18e-09 | 18 | 29 | 4 | 11731482 | ||
| Pubmed | 2.08e-09 | 4 | 29 | 3 | 15513934 | ||
| Pubmed | Reduced synaptic function of Kainate receptors in the insular cortex of Fmr1 Knock-out mice. | 2.08e-09 | 4 | 29 | 3 | 30241548 | |
| Pubmed | PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. | 2.08e-09 | 4 | 29 | 3 | 9887105 | |
| Pubmed | 2.08e-09 | 4 | 29 | 3 | 19369569 | ||
| Pubmed | Developmental expression patterns of kainate receptors in the mouse spinal cord. | 5.21e-09 | 5 | 29 | 3 | 23076118 | |
| Pubmed | Kainate receptors: pharmacology, function and therapeutic potential. | 5.21e-09 | 5 | 29 | 3 | 18793656 | |
| Pubmed | 5.21e-09 | 5 | 29 | 3 | 28228252 | ||
| Pubmed | 5.21e-09 | 5 | 29 | 3 | 12223554 | ||
| Pubmed | 5.21e-09 | 5 | 29 | 3 | 10748198 | ||
| Pubmed | 5.21e-09 | 5 | 29 | 3 | 18358623 | ||
| Pubmed | Development of laminar distributions of kainate receptors in the somatosensory cortex of mice. | 5.21e-09 | 5 | 29 | 3 | 9593973 | |
| Pubmed | Preferential assembly of heteromeric kainate and AMPA receptor amino terminal domains. | 5.21e-09 | 5 | 29 | 3 | 29058671 | |
| Pubmed | N-glycan content modulates kainate receptor functional properties. | 1.04e-08 | 6 | 29 | 3 | 28714086 | |
| Pubmed | 1.82e-08 | 7 | 29 | 3 | 17428973 | ||
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 1.82e-08 | 7 | 29 | 3 | 9016303 | |
| Pubmed | 1.82e-08 | 7 | 29 | 3 | 19342380 | ||
| Pubmed | Glutamate receptors: brain function and signal transduction. | 1.82e-08 | 7 | 29 | 3 | 9651535 | |
| Pubmed | 1.82e-08 | 7 | 29 | 3 | 1310861 | ||
| Pubmed | Six3 and Six6 activity is modulated by members of the groucho family. | 2.91e-08 | 8 | 29 | 3 | 12441302 | |
| Pubmed | Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9. | 2.91e-08 | 8 | 29 | 3 | 28296634 | |
| Pubmed | Transmembrane topology of the glutamate receptor subunit GluR6. | 2.91e-08 | 8 | 29 | 3 | 8163463 | |
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 4.36e-08 | 9 | 29 | 3 | 9051806 | |
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 1.48e-07 | 13 | 29 | 3 | 20859245 | |
| Pubmed | 4.22e-07 | 18 | 29 | 3 | 22434868 | ||
| Pubmed | TCF and Groucho-related genes influence pituitary growth and development. | 4.22e-07 | 18 | 29 | 3 | 12907761 | |
| Pubmed | 5.01e-07 | 19 | 29 | 3 | 9070936 | ||
| Pubmed | Transcriptional regulation of cortical neuron migration by POU domain factors. | 5.89e-07 | 20 | 29 | 3 | 11859196 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 12947409 | ||
| Pubmed | Assessing the role of GLUK5 and GLUK6 at hippocampal mossy fiber synapses. | 6.71e-07 | 2 | 29 | 2 | 15537878 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 15673679 | ||
| Pubmed | Subunit composition of kainate receptors in hippocampal interneurons. | 6.71e-07 | 2 | 29 | 2 | 11144357 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 10831834 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 19320626 | ||
| Pubmed | Grg1 acts as a lung-specific oncogene in a transgenic mouse model. | 6.71e-07 | 2 | 29 | 2 | 16452182 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 25043179 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 15094479 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 11182092 | ||
| Pubmed | Kainate receptor-mediated synaptic transmission in the adult anterior cingulate cortex. | 6.71e-07 | 2 | 29 | 2 | 15928066 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 16381801 | ||
| Pubmed | Chondroitin sulfate synthase-3. Molecular cloning and characterization. | 6.71e-07 | 2 | 29 | 2 | 12907687 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 15358807 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 14724198 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 17620617 | ||
| Pubmed | Q/R site editing in kainate receptor GluR5 and GluR6 pre-mRNAs requires distant intronic sequences. | 6.71e-07 | 2 | 29 | 2 | 8700852 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 15539395 | ||
| Pubmed | Gro/TLE enables embryonic stem cell differentiation by repressing pluripotent gene expression. | 6.71e-07 | 2 | 29 | 2 | 25446531 | |
| Pubmed | Differential functions of TLE1 and TLE3 depending on a specific phosphorylation site. | 6.71e-07 | 2 | 29 | 2 | 33571907 | |
| Pubmed | Role of GluK1 kainate receptors in seizures, epileptic discharges, and epileptogenesis. | 6.71e-07 | 2 | 29 | 2 | 24760837 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 36801171 | ||
| Pubmed | A mosaic of functional kainate receptors in hippocampal interneurons. | 6.71e-07 | 2 | 29 | 2 | 15483117 | |
| Pubmed | Functional characterization of kainate receptors in the mouse nucleus accumbens. | 6.71e-07 | 2 | 29 | 2 | 11985817 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 7696618 | ||
| Pubmed | Atypical functional properties of GluK3-containing kainate receptors. | 6.71e-07 | 2 | 29 | 2 | 20007474 | |
| Pubmed | Q/R site editing controls kainate receptor inhibition by membrane fatty acids. | 6.71e-07 | 2 | 29 | 2 | 16221857 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 16219388 | ||
| Pubmed | Expression and novel subunit isoforms of glutamate receptor genes GluR5 and GluR6. | 6.71e-07 | 2 | 29 | 2 | 8260617 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 9572356 | ||
| Pubmed | Subunit composition and alternative splicing regulate membrane delivery of kainate receptors. | 6.71e-07 | 2 | 29 | 2 | 15014126 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 11069933 | ||
| Pubmed | 9.13e-07 | 23 | 29 | 3 | 8464923 | ||
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 1.04e-06 | 24 | 29 | 3 | 35746896 | |
| Pubmed | 1.04e-06 | 24 | 29 | 3 | 22534482 | ||
| Pubmed | 1.68e-06 | 28 | 29 | 3 | 17041588 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 38996073 | ||
| Pubmed | Groucho binds two conserved regions of LEF-1 for HDAC-dependent repression. | 2.01e-06 | 3 | 29 | 2 | 19460168 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 10825294 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 18258796 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 15509753 | ||
| Pubmed | Chondroitin synthase-3 regulates nucleus pulposus degeneration through actin-induced YAP signaling. | 2.01e-06 | 3 | 29 | 2 | 33089528 | |
| Pubmed | TLE1 is an anoikis regulator and is downregulated by Bit1 in breast cancer cells. | 2.01e-06 | 3 | 29 | 2 | 22952044 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 12030375 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 32567721 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 7538211 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 22354967 | ||
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 2.01e-06 | 3 | 29 | 2 | 24523520 | |
| Interaction | RIPPLY2 interactions | 6.55e-11 | 20 | 29 | 5 | int:RIPPLY2 | |
| Interaction | SIX6 interactions | 1.13e-09 | 11 | 29 | 4 | int:SIX6 | |
| Interaction | HLX interactions | 1.81e-09 | 37 | 29 | 5 | int:HLX | |
| Interaction | RIPPLY1 interactions | 1.42e-08 | 55 | 29 | 5 | int:RIPPLY1 | |
| Interaction | SIX3 interactions | 1.65e-08 | 20 | 29 | 4 | int:SIX3 | |
| Interaction | MFAP4 interactions | 4.03e-08 | 139 | 29 | 6 | int:MFAP4 | |
| Interaction | ISX interactions | 1.06e-07 | 31 | 29 | 4 | int:ISX | |
| Interaction | PRDM1 interactions | 1.22e-07 | 84 | 29 | 5 | int:PRDM1 | |
| Interaction | GRIK4 interactions | 1.49e-07 | 8 | 29 | 3 | int:GRIK4 | |
| Interaction | TLE4 interactions | 1.93e-07 | 92 | 29 | 5 | int:TLE4 | |
| Interaction | MSX1 interactions | 1.97e-07 | 36 | 29 | 4 | int:MSX1 | |
| Interaction | GRIK3 interactions | 3.19e-07 | 10 | 29 | 3 | int:GRIK3 | |
| Interaction | VENTX interactions | 3.57e-07 | 104 | 29 | 5 | int:VENTX | |
| Interaction | EN1 interactions | 4.73e-07 | 110 | 29 | 5 | int:EN1 | |
| Interaction | RIPPLY3 interactions | 5.17e-07 | 112 | 29 | 5 | int:RIPPLY3 | |
| Interaction | SIX1 interactions | 7.00e-07 | 49 | 29 | 4 | int:SIX1 | |
| Interaction | TLE3 interactions | 8.15e-07 | 376 | 29 | 7 | int:TLE3 | |
| Interaction | HES6 interactions | 8.92e-07 | 52 | 29 | 4 | int:HES6 | |
| Interaction | PAX9 interactions | 1.08e-06 | 130 | 29 | 5 | int:PAX9 | |
| Interaction | TLE2 interactions | 1.36e-06 | 136 | 29 | 5 | int:TLE2 | |
| Interaction | VSX1 interactions | 2.34e-06 | 66 | 29 | 4 | int:VSX1 | |
| Interaction | GRIK5 interactions | 3.00e-06 | 20 | 29 | 3 | int:GRIK5 | |
| Interaction | TBX20 interactions | 3.50e-06 | 21 | 29 | 3 | int:TBX20 | |
| Interaction | SMG7 interactions | 5.24e-06 | 319 | 29 | 6 | int:SMG7 | |
| Interaction | GATA3 interactions | 6.46e-06 | 187 | 29 | 5 | int:GATA3 | |
| Interaction | GSC interactions | 7.09e-06 | 87 | 29 | 4 | int:GSC | |
| Interaction | FOXL1 interactions | 8.12e-06 | 196 | 29 | 5 | int:FOXL1 | |
| Interaction | FOXI1 interactions | 8.85e-06 | 92 | 29 | 4 | int:FOXI1 | |
| Interaction | SIX2 interactions | 9.55e-06 | 29 | 29 | 3 | int:SIX2 | |
| Interaction | TLE1 interactions | 1.22e-05 | 213 | 29 | 5 | int:TLE1 | |
| Interaction | GRIK2 interactions | 1.29e-05 | 32 | 29 | 3 | int:GRIK2 | |
| Interaction | GRIK1 interactions | 1.85e-05 | 36 | 29 | 3 | int:GRIK1 | |
| Interaction | PAX8 interactions | 1.86e-05 | 111 | 29 | 4 | int:PAX8 | |
| Interaction | TBR1 interactions | 2.00e-05 | 113 | 29 | 4 | int:TBR1 | |
| Interaction | TBXT interactions | 2.21e-05 | 116 | 29 | 4 | int:TBXT | |
| Interaction | STARD7 interactions | 2.36e-05 | 39 | 29 | 3 | int:STARD7 | |
| Interaction | PAX7 interactions | 2.88e-05 | 124 | 29 | 4 | int:PAX7 | |
| Interaction | BARHL1 interactions | 4.18e-05 | 7 | 29 | 2 | int:BARHL1 | |
| Interaction | TLX2 interactions | 4.89e-05 | 142 | 29 | 4 | int:TLX2 | |
| Interaction | TLX3 interactions | 5.42e-05 | 291 | 29 | 5 | int:TLX3 | |
| Interaction | FOXA3 interactions | 5.65e-05 | 52 | 29 | 3 | int:FOXA3 | |
| Interaction | HHEX interactions | 6.32e-05 | 54 | 29 | 3 | int:HHEX | |
| Interaction | SP7 interactions | 6.67e-05 | 304 | 29 | 5 | int:SP7 | |
| Interaction | ZNF503 interactions | 7.44e-05 | 57 | 29 | 3 | int:ZNF503 | |
| Interaction | GATA1 interactions | 1.01e-04 | 171 | 29 | 4 | int:GATA1 | |
| Interaction | TLX1 interactions | 1.10e-04 | 175 | 29 | 4 | int:TLX1 | |
| Interaction | RBM14 interactions | 1.15e-04 | 553 | 29 | 6 | int:RBM14 | |
| Interaction | LCN6 interactions | 1.21e-04 | 67 | 29 | 3 | int:LCN6 | |
| Interaction | DZIP3 interactions | 1.31e-04 | 183 | 29 | 4 | int:DZIP3 | |
| Interaction | LEF1 interactions | 1.32e-04 | 69 | 29 | 3 | int:LEF1 | |
| Interaction | GATA2 interactions | 1.81e-04 | 199 | 29 | 4 | int:GATA2 | |
| Interaction | FEV interactions | 1.95e-04 | 203 | 29 | 4 | int:FEV | |
| Interaction | CABP1 interactions | 2.08e-04 | 15 | 29 | 2 | int:CABP1 | |
| Interaction | QPRT interactions | 2.36e-04 | 84 | 29 | 3 | int:QPRT | |
| Interaction | PAX2 interactions | 2.44e-04 | 85 | 29 | 3 | int:PAX2 | |
| Interaction | IRF4 interactions | 2.44e-04 | 85 | 29 | 3 | int:IRF4 | |
| Interaction | ATP2A1 interactions | 3.12e-04 | 423 | 29 | 5 | int:ATP2A1 | |
| Interaction | KALRN interactions | 3.50e-04 | 96 | 29 | 3 | int:KALRN | |
| Interaction | TLE5 interactions | 3.85e-04 | 443 | 29 | 5 | int:TLE5 | |
| Interaction | MYL11 interactions | 4.13e-04 | 21 | 29 | 2 | int:MYL11 | |
| Interaction | CLOCK interactions | 4.18e-04 | 102 | 29 | 3 | int:CLOCK | |
| Interaction | UTY interactions | 4.96e-04 | 23 | 29 | 2 | int:UTY | |
| Interaction | ZFHX3 interactions | 5.08e-04 | 109 | 29 | 3 | int:ZFHX3 | |
| Interaction | MYCBPAP interactions | 7.92e-04 | 29 | 29 | 2 | int:MYCBPAP | |
| Interaction | FOXB1 interactions | 9.46e-04 | 135 | 29 | 3 | int:FOXB1 | |
| Interaction | PLAUR interactions | 9.46e-04 | 135 | 29 | 3 | int:PLAUR | |
| Interaction | GFI1B interactions | 9.66e-04 | 136 | 29 | 3 | int:GFI1B | |
| Interaction | FOXQ1 interactions | 1.07e-03 | 141 | 29 | 3 | int:FOXQ1 | |
| Interaction | SOX15 interactions | 1.07e-03 | 141 | 29 | 3 | int:SOX15 | |
| Interaction | NFIB interactions | 1.09e-03 | 142 | 29 | 3 | int:NFIB | |
| Interaction | RUNX1 interactions | 1.13e-03 | 324 | 29 | 4 | int:RUNX1 | |
| Interaction | MAD2L2 interactions | 1.15e-03 | 325 | 29 | 4 | int:MAD2L2 | |
| Interaction | CHSY3 interactions | 1.22e-03 | 36 | 29 | 2 | int:CHSY3 | |
| Interaction | CPSF7 interactions | 1.33e-03 | 338 | 29 | 4 | int:CPSF7 | |
| Interaction | NOTCH1 interactions | 1.43e-03 | 345 | 29 | 4 | int:NOTCH1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q21 | 7.03e-03 | 199 | 29 | 2 | chr9q21 | |
| Cytoband | 19p13.3 | 9.83e-03 | 237 | 29 | 2 | 19p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.36e-02 | 797 | 29 | 3 | chr19p13 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 1.56e-08 | 5 | 22 | 3 | 1199 | |
| GeneFamily | Beta 4-glycosyltransferases | 1.90e-04 | 17 | 22 | 2 | 425 | |
| GeneFamily | WD repeat domain containing | 2.57e-04 | 262 | 22 | 4 | 362 | |
| GeneFamily | Beta 3-glycosyltransferases | 3.84e-04 | 24 | 22 | 2 | 426 | |
| GeneFamily | Calcium voltage-gated channel subunits | 4.51e-04 | 26 | 22 | 2 | 253 | |
| Coexpression | GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_DN | 2.46e-06 | 199 | 29 | 5 | M4673 | |
| Coexpression | GSE36078_WT_VS_IL1R_KO_LUNG_DC_DN | 2.52e-06 | 200 | 29 | 5 | M9290 | |
| Coexpression | GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN | 6.34e-05 | 197 | 29 | 4 | M6835 | |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_UP | 6.73e-05 | 200 | 29 | 4 | M10032 | |
| Coexpression | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN | 8.43e-05 | 77 | 29 | 3 | M17937 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | 9.10e-05 | 1009 | 29 | 7 | M157 | |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | 1.12e-04 | 441 | 29 | 5 | M172 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.04e-06 | 167 | 29 | 4 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.24e-06 | 169 | 29 | 4 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | Severe-B_naive-8|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.76e-06 | 174 | 29 | 4 | f3f8c924420f46321bd47e2b97f18c7241541599 | |
| ToppCell | Mild/Remission-B_naive-8|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.47e-06 | 195 | 29 | 4 | 0a3221e4d1fa31a35868bdda0f0cc873c233b407 | |
| ToppCell | Severe-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.77e-06 | 197 | 29 | 4 | 0905417e3fa7424575bc48e8054256d5799306d7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.25e-06 | 200 | 29 | 4 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.25e-06 | 200 | 29 | 4 | 8d51b4f7b7002ee51401ebe5eaca1e8f04bfadd5 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.25e-06 | 200 | 29 | 4 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.25e-06 | 200 | 29 | 4 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.25e-06 | 200 | 29 | 4 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.25e-06 | 200 | 29 | 4 | 6a44439e4a7ce3627271375b04cfcfb9467218f4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.25e-06 | 200 | 29 | 4 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.25e-06 | 200 | 29 | 4 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A--L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.25e-06 | 200 | 29 | 4 | cb1f4b0d66da5b0466ff17b29e7034d451d93e4f | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.25e-06 | 200 | 29 | 4 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.25e-06 | 200 | 29 | 4 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.25e-06 | 200 | 29 | 4 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.34e-05 | 131 | 29 | 3 | 9ca209a8652aae603c4a867ea06b06ac51e7d189 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.30e-04 | 152 | 29 | 3 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-Treg|Leuk-UTI / Disease, Lineage and Cell Type | 1.32e-04 | 153 | 29 | 3 | b24c693b142206d13b29c96faa7f79a1a22bc2ef | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.77e-04 | 169 | 29 | 3 | d9c3b22f62b882b8a2ea6fd9cf7afbe6d1775745 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.77e-04 | 169 | 29 | 3 | 96a2aec9acf8a6f966973c035e5ade456cf47772 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-04 | 171 | 29 | 3 | 6a2f88c2a62cb2f69797804e24eb1137a3e148de | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-04 | 171 | 29 | 3 | 9be3554626408bb897d1f1c43b3ab4a92651f2e2 | |
| ToppCell | Mild/Remission-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.90e-04 | 173 | 29 | 3 | 694d02c4d2dc2de4b344544f9124fec40fcf7d8f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.90e-04 | 173 | 29 | 3 | 0ba64e5385fe714f876002520f8b5202809bf11e | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.93e-04 | 174 | 29 | 3 | 9f114e61458659005b6d0b4aa30a7a059e7aa5c6 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-04 | 175 | 29 | 3 | 182e45f5c02214d6b9f317ff5dc43af8b42de978 | |
| ToppCell | wk_15-18-Epithelial-PNS-COL20A1+_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.03e-04 | 177 | 29 | 3 | b8cc6a7abf83a9844a5293b6cc4b19135b51fd53 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_TH|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.10e-04 | 179 | 29 | 3 | 797d165718dd1d819e65add3a7859f87b32238a5 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.10e-04 | 179 | 29 | 3 | ec1d7017da325647b629de703135a404bbdc627d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-04 | 179 | 29 | 3 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | 5'-Adult-LymphNode-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.13e-04 | 180 | 29 | 3 | cc974ac352ef2adc953fb5f325880e5857595889 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.13e-04 | 180 | 29 | 3 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | critical-Lymphoid-NK|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.13e-04 | 180 | 29 | 3 | 5abf778395392244daaec876f306ed7e4f388686 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.17e-04 | 181 | 29 | 3 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.17e-04 | 181 | 29 | 3 | ca34d83daca10c5fa52ecdf4eba7d31b4e7e056e | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 2.20e-04 | 182 | 29 | 3 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-04 | 182 | 29 | 3 | d1c3cc2942faec7527a3c25869fd65c17899e5e4 | |
| ToppCell | 5'-Adult-LymphNode-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-04 | 182 | 29 | 3 | cf0a6f99b825eb75f95f376c16a504e2669820ac | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.20e-04 | 182 | 29 | 3 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.20e-04 | 182 | 29 | 3 | f7f9be9c7ef8da9864d6aefe20043b26e1bb8697 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.20e-04 | 182 | 29 | 3 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | Influenza_Severe-B_naive|World / Disease group and Cell class | 2.20e-04 | 182 | 29 | 3 | e4885a5e6065c9c403cb2d305228691d6ae4ecb6 | |
| ToppCell | 5'-Adult-LymphNode-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-04 | 182 | 29 | 3 | 49e4b362f88d235ed12aabcabb54787c16e32cb7 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-04 | 182 | 29 | 3 | 92f83f29e358000cd86a709eb8b6199761ffe8bd | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-04 | 182 | 29 | 3 | 02baca9a72c7b559c3e452693b3b134af804c868 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.24e-04 | 183 | 29 | 3 | f517215ff45dec914af52dfdbc4579c19654c3aa | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.31e-04 | 185 | 29 | 3 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.31e-04 | 185 | 29 | 3 | a8946379fc066903fe8f4bc9cbf693b7b424a0cd | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-04 | 186 | 29 | 3 | aeac0c2db173cd1ea45b5052ab418d6cacd198d8 | |
| ToppCell | Control-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 2.35e-04 | 186 | 29 | 3 | 7bc939bf4e71bb4c6409b862c1f6c547d775e089 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-04 | 187 | 29 | 3 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-8|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.38e-04 | 187 | 29 | 3 | c10d6a774b3e83f64e47b9ad08f5d6b0dc60d163 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.38e-04 | 187 | 29 | 3 | f31d865ce2a21bdf64dbe29ee3e4505ab482604a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-04 | 187 | 29 | 3 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | COVID-19_Severe-B_memory|World / disease group, cell group and cell class | 2.38e-04 | 187 | 29 | 3 | f29c71f2505bb64f3010ada491d422b87a6f7db3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.42e-04 | 188 | 29 | 3 | f7dc29dfec68236883469e848be5db34f5526d6b | |
| ToppCell | normal-na-Lymphocytic_B-B_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.42e-04 | 188 | 29 | 3 | ec72ba73b10c6f2ff39699b6b46b90a3e95a4c24 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.42e-04 | 188 | 29 | 3 | 5ae8ccdd328cf117da1d01ced2c3b7f763a5f1f1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.42e-04 | 188 | 29 | 3 | d8decd9b5967873ca8320c2f9f07365f163c777f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.42e-04 | 188 | 29 | 3 | 9abd78970bbe4ed03b59a83da63bbd334712f605 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.46e-04 | 189 | 29 | 3 | e2bb5900d210386b7b74938e7a3636d0c7ba1bcf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 189 | 29 | 3 | bfc76a72b600d641c8fe58346e5d8986c34f3981 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.46e-04 | 189 | 29 | 3 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.50e-04 | 190 | 29 | 3 | 56cc761e50fddfb5366391518b4d8e16589b6b42 | |
| ToppCell | wk_08-11-Epithelial-PNS-Schwann_precursor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.50e-04 | 190 | 29 | 3 | 4a777d8aa19cadd3b61b023772df142421a89113 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-04 | 190 | 29 | 3 | b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.50e-04 | 190 | 29 | 3 | 25d4b591f75c26e404a34c42f1742d580af6598d | |
| ToppCell | severe-B_naive|World / disease stage, cell group and cell class | 2.50e-04 | 190 | 29 | 3 | 8dfe067d75573289299a5fba42b6c9b26e5fb430 | |
| ToppCell | severe-B_naive|severe / disease stage, cell group and cell class | 2.50e-04 | 190 | 29 | 3 | 2430a1fd18385305bf1b604747ff64026a8d5edf | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.54e-04 | 191 | 29 | 3 | b374676ac90572d65895052d46469906e2b6fd93 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Th17_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.58e-04 | 192 | 29 | 3 | 12f7ea575da5d650c740e6060f5dab0478e563dd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-04 | 192 | 29 | 3 | 2510f22197502f60fd266b7f42eff040f25b8ae7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-04 | 192 | 29 | 3 | e8e316f396834bcd34843e56e1d86f310fd6aada | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.58e-04 | 192 | 29 | 3 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.58e-04 | 192 | 29 | 3 | 800edadd1d1ba6b7e0a0398030dd4b61c9c480c7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.58e-04 | 192 | 29 | 3 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-04 | 193 | 29 | 3 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.62e-04 | 193 | 29 | 3 | 3ea6b103e35bbb276e95301999618558fa3e38b1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-04 | 193 | 29 | 3 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | normal-na-Lymphocytic_B-B_naive|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.62e-04 | 193 | 29 | 3 | 98279a3c69f1df062c4a8333e46c8fd649bf86b1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-04 | 193 | 29 | 3 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-04 | 193 | 29 | 3 | 9f9eb241b0b82a6f12de6921c3acf6fed7cf65bb | |
| ToppCell | normal-na-Lymphocytic_B-B_naive-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.62e-04 | 193 | 29 | 3 | dd199163fc13f3d411fe741cf003237064349e22 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-04 | 193 | 29 | 3 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | severe_influenza-B_naive|World / disease group, cell group and cell class (v2) | 2.62e-04 | 193 | 29 | 3 | c52ba94782ad57b93d20f853a89344dffa8351f9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-04 | 193 | 29 | 3 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-04 | 193 | 29 | 3 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-04 | 193 | 29 | 3 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-04 | 193 | 29 | 3 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-04 | 193 | 29 | 3 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | severe_influenza-B_naive|severe_influenza / disease group, cell group and cell class (v2) | 2.66e-04 | 194 | 29 | 3 | 7c1e9ce5de3bb1657a67010de673c8bb60129cb6 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.66e-04 | 194 | 29 | 3 | e9c907b8ec4329946338cca5ce8e954fa2cec37b | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.66e-04 | 194 | 29 | 3 | 24f9de4781666c96c4a2d04f8a444543dbd99cbe | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.66e-04 | 194 | 29 | 3 | f44394c8a6f86483063f2f5722f003a8a0a70254 | |
| ToppCell | Control-Lymphoid_B-B_naive|Control / Disease group, lineage and cell class | 2.66e-04 | 194 | 29 | 3 | 4f9600960a287cfc020c06b4af3528d4e5797916 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 194 | 29 | 3 | ad1aacff97beb76f4211942676e1d5e84087d44e | |
| ToppCell | COVID-19_Severe-B_naive|World / disease group, cell group and cell class | 2.66e-04 | 194 | 29 | 3 | d363963a6caeedf4f9e9ad22dcf9b66b85c79a48 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.66e-04 | 194 | 29 | 3 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| Computational | Ion channels. | 2.38e-04 | 70 | 19 | 3 | MODULE_316 | |
| Drug | riluzole | 7.50e-08 | 174 | 29 | 6 | CID000005070 | |
| Drug | hexachlorophene | 9.50e-08 | 90 | 29 | 5 | CID000003598 | |
| Drug | LY339434 | 1.55e-07 | 9 | 29 | 3 | CID006324635 | |
| Drug | LY354740 | 5.09e-07 | 51 | 29 | 4 | CID000114827 | |
| Drug | GYKI 52466 | 8.58e-07 | 58 | 29 | 4 | CID000003538 | |
| Drug | decahydroisoquinoline | 1.03e-06 | 16 | 29 | 3 | CID000097812 | |
| Drug | 5-nitro-6,7,8,9-tetrahydrobenzo(G)indole-2,3-dione-3-oxime | 1.57e-06 | 2 | 29 | 2 | ctd:C084273 | |
| Drug | LY382884 | 1.78e-06 | 19 | 29 | 3 | CID000656723 | |
| Drug | NS 102 | 2.81e-06 | 22 | 29 | 3 | CID005282252 | |
| Drug | NSC7524 | 3.14e-06 | 182 | 29 | 5 | CID000005657 | |
| Drug | caffeine | 5.24e-06 | 562 | 29 | 7 | CID000002519 | |
| Drug | 2-amino-4-phosphonobutyric acid | 5.25e-06 | 91 | 29 | 4 | CID000002207 | |
| Drug | nitrendipine | 7.06e-06 | 98 | 29 | 4 | CID000004507 | |
| Drug | LY293558 | 7.37e-06 | 30 | 29 | 3 | CID000127894 | |
| Drug | isradipine | 7.65e-06 | 100 | 29 | 4 | CID000003784 | |
| Drug | 4-methylglutamic acid | 8.15e-06 | 31 | 29 | 3 | CID000005365 | |
| Drug | cobalt-60 | 8.27e-06 | 390 | 29 | 6 | CID000061492 | |
| Drug | cyclothiazide | 8.60e-06 | 103 | 29 | 4 | CID000002910 | |
| Drug | willardine | 8.99e-06 | 32 | 29 | 3 | CID000005123 | |
| Drug | 3-aminopropylphosphinic acid | 8.99e-06 | 32 | 29 | 3 | CID006335948 | |
| Drug | AC 110 | 9.38e-06 | 4 | 29 | 2 | CID000022860 | |
| Drug | aminothiazole 6 | 9.38e-06 | 4 | 29 | 2 | CID005329388 | |
| Drug | acromelic acid B | 9.38e-06 | 4 | 29 | 2 | CID000158974 | |
| Drug | Brn 1074551 | 9.38e-06 | 4 | 29 | 2 | CID000120220 | |
| Drug | diCl-HQC | 9.38e-06 | 4 | 29 | 2 | CID003018579 | |
| Drug | CNS 1145 | 9.88e-06 | 33 | 29 | 3 | CID000190902 | |
| Drug | IHC-64 | 9.88e-06 | 33 | 29 | 3 | CID000162753 | |
| Drug | DB08464 | 1.24e-05 | 113 | 29 | 4 | CID011373270 | |
| Drug | lamotrigine | 1.38e-05 | 116 | 29 | 4 | CID000003878 | |
| Drug | 8-cyclopentyltheophylline | 1.52e-05 | 38 | 29 | 3 | CID000001917 | |
| Drug | L-BMAA | 1.52e-05 | 38 | 29 | 3 | CID000028558 | |
| Drug | 3-hydroxy-2-quinoxalinecarboxylic acid | 1.56e-05 | 5 | 29 | 2 | CID000071001 | |
| Drug | bromowillardiine | 1.56e-05 | 5 | 29 | 2 | CID000167842 | |
| Drug | ipenoxazone | 1.56e-05 | 5 | 29 | 2 | CID000065882 | |
| Drug | pBB-PzDA | 1.56e-05 | 5 | 29 | 2 | CID000124528 | |
| Drug | DETC-MeSO | 1.65e-05 | 39 | 29 | 3 | CID003035711 | |
| Drug | Joro spider toxin | 2.22e-05 | 43 | 29 | 3 | CID000119582 | |
| Drug | 3-acetylisoquinoline | 2.34e-05 | 6 | 29 | 2 | CID000124656 | |
| Drug | 3,4-dihydroquinazoline | 2.34e-05 | 6 | 29 | 2 | CID000583065 | |
| Drug | alpha-sialylcholesterol | 2.34e-05 | 6 | 29 | 2 | CID000133976 | |
| Drug | gamma-aminobutyric acid | 2.49e-05 | 474 | 29 | 6 | CID000000119 | |
| Drug | philanthotoxin | 2.54e-05 | 45 | 29 | 3 | CID000115201 | |
| Drug | fluorocyclobutane | 3.28e-05 | 7 | 29 | 2 | CID011051569 | |
| Drug | APMPA | 3.28e-05 | 7 | 29 | 2 | CID000512300 | |
| Drug | Dantrolene-13C3 | 3.31e-05 | 145 | 29 | 4 | CID000002951 | |
| Drug | nimodipine | 3.31e-05 | 145 | 29 | 4 | CID000004497 | |
| Drug | AC1L1DXE | 3.46e-05 | 299 | 29 | 5 | CID000002548 | |
| Drug | AC1L1FA8 | 3.50e-05 | 50 | 29 | 3 | CID000003150 | |
| Drug | AC1L1EKQ | 3.94e-05 | 52 | 29 | 3 | CID000002834 | |
| Drug | N-Ac-D-E | 4.17e-05 | 53 | 29 | 3 | CID000005255 | |
| Drug | AC1L1B65 | 4.37e-05 | 8 | 29 | 2 | CID000001300 | |
| Drug | perzinfotel | 4.37e-05 | 8 | 29 | 2 | CID006918236 | |
| Drug | Cinildipine | 4.92e-05 | 56 | 29 | 3 | CID000002752 | |
| Drug | SR 48968 | 5.47e-05 | 58 | 29 | 3 | CID000104974 | |
| Drug | myo-inositol | 5.57e-05 | 811 | 29 | 7 | CID000000892 | |
| Drug | Ly294486 | 5.61e-05 | 9 | 29 | 2 | CID005311255 | |
| Drug | 1m5b | 5.61e-05 | 9 | 29 | 2 | CID000447081 | |
| Drug | benzo(F)quinoxaline | 5.61e-05 | 9 | 29 | 2 | CID000098494 | |
| Drug | gabapentin | 6.02e-05 | 169 | 29 | 4 | CID000003446 | |
| Drug | nilvadipine | 6.05e-05 | 60 | 29 | 3 | CID000004494 | |
| Drug | IAA-94 | 6.36e-05 | 61 | 29 | 3 | CID000003667 | |
| Drug | 3,7-diaminoheptan-2-one | 6.36e-05 | 61 | 29 | 3 | CID004477684 | |
| Drug | EGTA-AM | 6.68e-05 | 62 | 29 | 3 | CID000121907 | |
| Drug | HFPA | 7.00e-05 | 10 | 29 | 2 | CID003035614 | |
| Drug | 2bvx | 7.00e-05 | 10 | 29 | 2 | CID011957382 | |
| Drug | Benzoates | 7.00e-05 | 10 | 29 | 2 | ctd:D001565 | |
| Drug | lercanidipine | 7.01e-05 | 63 | 29 | 3 | CID000065866 | |
| Drug | papaverine | 7.05e-05 | 176 | 29 | 4 | CID000004680 | |
| Drug | AC1L3VFE | 7.70e-05 | 65 | 29 | 3 | CID000122880 | |
| Drug | gallopamil | 8.43e-05 | 67 | 29 | 3 | CID000001234 | |
| Drug | sym 2206 | 8.55e-05 | 11 | 29 | 2 | CID005039877 | |
| Drug | leys | 8.55e-05 | 11 | 29 | 2 | CID000484683 | |
| Drug | DCG-IV | 8.81e-05 | 68 | 29 | 3 | CID000115114 | |
| Drug | L-Glutamic Acid | 8.81e-05 | 68 | 29 | 3 | DB00142 | |
| Drug | AC1L2AC7 | 9.20e-05 | 69 | 29 | 3 | CID000068733 | |
| Drug | felbamate | 9.60e-05 | 70 | 29 | 3 | CID000003331 | |
| Drug | baclofen | 9.67e-05 | 191 | 29 | 4 | CID000002284 | |
| Drug | AC1L2VU3 | 1.03e-04 | 12 | 29 | 2 | CID000129572 | |
| Drug | Atpa | 1.03e-04 | 12 | 29 | 2 | CID000002252 | |
| Drug | novobiocin sodium, USP; Down 200; 100uM; SKMEL5; HG-U133A | 1.05e-04 | 195 | 29 | 4 | 632_DN | |
| Drug | CAS 298-57-7 | 1.09e-04 | 73 | 29 | 3 | CID000002761 | |
| Drug | Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 4096_DN | |
| Drug | valproate | 1.09e-04 | 381 | 29 | 5 | CID000003121 | |
| Drug | Bromopride [4093-35-0]; Up 200; 11.6uM; PC3; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 4278_UP | |
| Drug | gadolinium | 1.13e-04 | 199 | 29 | 4 | CID000023982 | |
| Drug | 1,3-dipropylxanthine | 1.13e-04 | 74 | 29 | 3 | CID000169317 | |
| Drug | ethosuximide | 1.13e-04 | 74 | 29 | 3 | CID000003291 | |
| Drug | AC1L1E5T | 1.13e-04 | 74 | 29 | 3 | CID000002653 | |
| Drug | AC1L1DME | 1.18e-04 | 75 | 29 | 3 | CID000002414 | |
| Drug | glufosinate | 1.23e-04 | 76 | 29 | 3 | CID000004794 | |
| Drug | haloperidol | 1.28e-04 | 394 | 29 | 5 | CID000003559 | |
| Drug | nisoldipine | 1.33e-04 | 78 | 29 | 3 | CID000004499 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 1.38e-04 | 79 | 29 | 3 | CID005287890 | |
| Drug | N-methyl-DL-aspartic acid | 1.50e-04 | 655 | 29 | 6 | CID000004376 | |
| Drug | nifedipine | 1.63e-04 | 415 | 29 | 5 | CID000004485 | |
| Drug | butamben | 1.63e-04 | 15 | 29 | 2 | CID000002482 | |
| Drug | ACEA-1011 | 1.63e-04 | 15 | 29 | 2 | CID000127872 | |
| Drug | D-N-Q | 1.65e-04 | 84 | 29 | 3 | CID000003140 | |
| Drug | XeC compound | 1.65e-04 | 84 | 29 | 3 | CID000005701 | |
| Drug | AC1L9M5J | 1.70e-04 | 221 | 29 | 4 | CID000448615 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 2.80e-06 | 3 | 29 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 5.59e-06 | 4 | 29 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.95e-05 | 7 | 29 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | stroke outcome severity measurement | 1.91e-04 | 114 | 29 | 3 | EFO_0009603 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 3.87e-04 | 145 | 29 | 3 | DOID:1289 (implicated_via_orthology) | |
| Disease | unipolar depression, bipolar disorder | 4.79e-04 | 156 | 29 | 3 | EFO_0003761, MONDO_0004985 | |
| Disease | volumetric bone mineral density | 7.84e-04 | 42 | 29 | 2 | EFO_0007620 | |
| Disease | coronary artery calcification | 9.37e-04 | 450 | 29 | 4 | EFO_0004723 | |
| Disease | Bipolar Disorder | 1.16e-03 | 477 | 29 | 4 | C0005586 | |
| Disease | endometriosis | 1.91e-03 | 252 | 29 | 3 | EFO_0001065 | |
| Disease | neuroticism measurement, cognitive function measurement | 2.17e-03 | 566 | 29 | 4 | EFO_0007660, EFO_0008354 | |
| Disease | longevity | 2.68e-03 | 284 | 29 | 3 | EFO_0004300 | |
| Disease | calcium measurement | 3.16e-03 | 628 | 29 | 4 | EFO_0004838 | |
| Disease | Dystonia | 3.24e-03 | 86 | 29 | 2 | C0013421 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TVGKIYAAMMIMEYY | 1951 | O00555 | |
| ELAMEHRQFYKMSMY | 316 | Q6UWY0 | |
| GKIYAAMMIMDYYKQ | 1866 | Q15878 | |
| YKMGQMFMYDLYQSR | 91 | Q9P2I0 | |
| KQILFMGMMTEYYHY | 241 | P39086 | |
| GKTMVMDMFYAYVEM | 141 | Q8WV93 | |
| MAAYHMNTIYLQEMM | 806 | Q9UHI6 | |
| YKAMVMDMEFLYHVG | 2311 | Q14573 | |
| LEHFYMMPVNSEVMY | 61 | Q9BZD4 | |
| MDPICDFLYHMKYMF | 1291 | Q9ULK4 | |
| HYLMHNYPAFMMEMK | 141 | Q86TG7 | |
| FMTMNYGVHAVMYSY | 166 | Q9H5J4 | |
| QALAMGMMTEYYHYI | 241 | Q13002 | |
| MAMGMMTEYYHFIFT | 246 | Q13003 | |
| EEDLHKMLMVYFDYM | 691 | Q9Y6R4 | |
| YVMIAEKGEKLYHMM | 406 | Q8TCU6 | |
| SDMKYHIFQMMMQYL | 891 | Q8N961 | |
| HIFQMMMQYLYYGGT | 896 | Q8N961 | |
| MMQYLYYGGTESMEI | 901 | Q8N961 | |
| MMLKYMHDHYLDKYE | 151 | Q86X52 | |
| MMIKYMHDHYLDKYE | 241 | Q70JA7 | |
| EMQRHYVMYYEMSYG | 56 | Q08117 | |
| EMQRHYVMYYEMSYG | 56 | Q04724 | |
| MKSHLMVQMGEEYYY | 451 | Q7Z392 | |
| TEMQRHYVMYYEMSY | 61 | Q04727 | |
| LMYKMSYYRFGEMQL | 716 | Q8TCJ2 | |
| YTKLMNEDPMYSMYA | 371 | Q92783 | |
| EMQRHYVMYYEMSYG | 56 | Q04726 | |
| ICYFMMHYVDYSMMY | 171 | Q6NXT6 | |
| MHYVDYSMMYHLIRG | 176 | Q6NXT6 | |
| MQRHYVMYYEMSYGL | 56 | Q04725 | |
| VMYYEMSYGLNIEMH | 61 | Q04725 | |
| KYLQMVGMYASSYMI | 116 | P30518 |